Holen Sie sich die Stockscreener-App
2.70
0.00%
0.03
Schlusskurs vom Vortag:
$2.73
Offen:
$2.74
24-Stunden-Volumen:
36,778
Relative Volume:
0.01
Marktkapitalisierung:
$301.32M
Einnahmen:
$2.05B
Nettoeinkommen (Verlust:
$-128.18M
KGV:
-1.7202
EPS:
-1.5696
Netto-Cashflow:
$-68.67M
1W Leistung:
-10.46%
1M Leistung:
-34.29%
6M Leistung:
-70.28%
1J Leistung:
-72.21%
1-Tages-Spanne:
$2.70
$2.78
1-Wochen-Bereich:
$2.685
$3.13
52-Wochen-Spanne:
$2.685
$12.06
Evolent Health Inc Stock (EVH) Company Profile
Firmenname
Evolent Health Inc
Sektor
Branche
Telefon
571-389-6000
Adresse
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH vs VEEV, TEM, BTSG, HQY, DOCS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
2.70 | 304.67M | 2.05B | -128.18M | -68.67M | -1.5696 |
|
VEEV
Veeva Systems Inc
|
183.63 | 30.74B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
55.60 | 9.94B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
BTSG
Brightspring Health Services Inc
|
39.52 | 7.10B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
78.55 | 6.69B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
27.09 | 5.08B | 550.17M | 201.35M | 232.07M | 1.00 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-11-13 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-03 | Bestätigt | BTIG Research | Buy |
| 2024-11-08 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-09 | Hochstufung | Truist | Hold → Buy |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-10-16 | Eingeleitet | UBS | Buy |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2022-11-01 | Eingeleitet | Truist | Hold |
| 2022-07-29 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2021-11-18 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-29 | Fortgesetzt | JP Morgan | Neutral |
| 2021-01-07 | Eingeleitet | BTIG Research | Buy |
| 2020-07-06 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-06-05 | Herabstufung | Goldman | Buy → Neutral |
| 2020-06-02 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2018-10-05 | Fortgesetzt | Leerink Partners | Outperform |
| 2018-06-04 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-04-24 | Fortgesetzt | JP Morgan | Neutral |
| 2017-09-20 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2017-06-02 | Eingeleitet | Robert W. Baird | Outperform |
| 2017-03-14 | Eingeleitet | Oppenheimer | Outperform |
| 2017-01-13 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-10-28 | Fortgesetzt | JP Morgan | Overweight |
| 2016-08-05 | Bestätigt | FBR Capital | Outperform |
| 2016-07-26 | Eingeleitet | Jefferies | Buy |
| 2016-07-13 | Bestätigt | FBR Capital | Outperform |
| 2016-03-29 | Eingeleitet | FBR Capital | Outperform |
| 2016-01-06 | Eingeleitet | Canaccord Genuity | Buy |
| 2015-06-30 | Eingeleitet | Goldman | Buy |
| 2015-06-30 | Eingeleitet | JP Morgan | Overweight |
| 2015-06-30 | Eingeleitet | Leerink Partners | Outperform |
| 2015-06-30 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Evolent Health Inc Aktie (EVH) Neueste Nachrichten
Valuation Update: Is Evolent Health Inc currently under institutional pressure2025 Bull vs Bear & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Evolent Health (EVH): From ACA Headwinds to Specialty Care Expansion - Finviz
Positive Sentiment Still Eludes Evolent Health, Inc. (NYSE:EVH) Following 28% Share Price Slump - 富途牛牛
Evolent To Release 2025 Fourth Quarter and Year-End Financial Results on Tuesday, February 24, 2026 - The Malaysian Reserve
1 Healthcare Stock to Target This Week and 2 We Find Risky - Yahoo Finance
Evolent Health to Release Q4 and Year-End 2025 Financial Results - intellectia.ai
Support Test: Is Evolent Health Inc affected by consumer sentiment2025 Momentum Check & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 164.92% Potential Upside in Healthcare Innovation - DirectorsTalk Interviews
Evolent Health to offer $140M in convertible notes, Targets 2025 debt, stock buyback - MSN
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist - Yahoo Finance
Evolent Health price target lowered to $10 from $16 at BTIG - TipRanks
Deep Dive Into Evolent Health Stock: Analyst Perspectives (11 Ratings) - Benzinga
Evolent Health (EVH) Price Target Lowered to $10 by BTIG | EVH S - GuruFocus
Income Plays: What is Evolent Health Inc. s 5 year growth outlookStop Loss & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Aug Final Week: What is the next catalyst for Evolent Health Inc.Inflation Watch & Short-Term High Return Strategies - mfd.ru
Evolent Health (NYSE:EVH) Focus Amid Nyse Composite Turbulence And Sector Pressure - Kalkine Media
Evolent Health (NYSE:EVH) Use Of Debt Could Be Considered Risky - 富途牛牛
Take Care Before Diving Into The Deep End On Evolent Health, Inc. (NYSE:EVH) - simplywall.st
Evolent Health, Inc. (EVH) Stock Analysis: Navigating a 147% Potential Upside Amidst Healthcare Challenges - DirectorsTalk Interviews
Evolent Health Announces Leadership Changes Amid Growth - MSN
Evolent Health (NYSE:EVH) Shares Cross Below 50 Day Moving AverageHere's What Happened - MarketBeat
Price-Driven Insight from (EVH) for Rule-Based Strategy - Stock Traders Daily
Ideas Watch: Is Evolent Health Inc a speculative investmentJuly 2025 Analyst Calls & Reliable Intraday Trade Plans - baoquankhu1.vn
Gains Recap: Is Evolent Health Inc affected by consumer sentimentNew Guidance & Risk Controlled Swing Alerts - baoquankhu1.vn
Earnings Recap: Is Central Plains Bancshares Inc forming a breakout patternJuly 2025 Chart Watch & High Yield Stock Recommendations - baoquankhu1.vn
Evolent Health (EVH): Can This Healthcare Innovator Deliver A 154% Upside? - DirectorsTalk Interviews
Gains Recap: Is Evolent Health Inc currently under institutional pressureEarnings Growth Report & Real-Time Volume Spike Alerts - baoquankhu1.vn
Aug Outlook: How sensitive is Evolent Health Inc to inflationJuly 2025 Action & Verified Swing Trading Watchlists - baoquankhu1.vn
Shorts Report: Whats next for Evolent Health Inc stock2025 Fundamental Recap & Intraday High Probability Alerts - baoquankhu1.vn
Market Wrap: Will Alvotech benefit from government policyJuly 2025 Reactions & Verified Entry Point Detection - baoquankhu1.vn
Canaccord cuts Evolent Health target to $16, maintains Buy - MSN
Signal Recap: Is now the right time to enter Evolent Health IncJuly 2025 Macro Moves & Growth Focused Stock Reports - baoquankhu1.vn
From Pilot to Program: Florida Blue Expands Cancer Support for Medicare Advantage Members - Florida Hospital News and Healthcare Report
Evolent Health (EVH) Price Target Decreased by 10.18% to 9.33 - Nasdaq
Market Fear: How Evolent Health Inc stock valuations compare to rivalsWeekly Trend Recap & Daily Profit Maximizing Tips - Bộ Nội Vụ
Loss Report: Will Evolent Health Inc stock recover faster than marketDividend Hike & Advanced Swing Trade Entry Alerts - Bộ Nội Vụ
Evolent Health, Inc. (EVH) Stock Analysis: A 131% Potential Upside Amidst Sector Challenges - DirectorsTalk Interviews
(EVH) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Evolent Health (EVH) Q1 Earnings Lag Estimates - sharewise.com
Does Evolent Health Inc. stock trade at a discount to peersQuarterly Trade Review & Daily Profit Maximizing Trade Tips - Улправда
How Evolent Health Inc. stock reacts to inflationary pressures2025 Volatility Report & Step-by-Step Swing Trade Plans - ulpravda.ru
Evolent Health Inc. Reports Strong Q3 Earnings and Strategic Growth - MSN
EVH: Citigroup Maintains Buy Rating, Lowers Price Target | EVH S - GuruFocus
Citigroup Lowers Evolent Health (NYSE:EVH) Price Target to $6.00 - MarketBeat
Aug Wrap: How Evolent Health Inc. stock reacts to bond yieldsTrend Reversal & Long-Term Growth Portfolio Plans - Улправда
Quarterly Earnings: How Evolent Health Inc stock reacts to job market dataQuarterly Market Summary & Free Safe Entry Trade Signal Reports - Bộ Nội Vụ
Entry Recap: How Evolent Health Inc. stock reacts to job market dataMarket Volume Report & Technical Pattern Recognition Alerts - Улправда
Setup Watch: How Evolent Health Inc. stock reacts to inflationary pressures2025 Investor Takeaways & Fast Gain Swing Alerts - ulpravda.ru
How sustainable is Evolent Health Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
How Evolent Health Inc. stock reacts to bond yieldsCPI Data & Fast Entry Momentum Trade Alerts - Улправда
How Evolent Health Inc. stock reacts to job market dataPortfolio Growth Summary & High Conviction Trade Alerts - ulpravda.ru
Finanzdaten der Evolent Health Inc-Aktie (EVH)
Umsatz
Nettogewinn
Free Cashflow
ENV
8.16%
0.92%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):